Circular RNAs in liver diseases: Mechanisms and therapeutic targets

Li-Yun Fu1, Shu-Wei Wang2, Meng-Yuan Hu2

  • 1Department of Infection and Hepatology, HwaMei Hospital, University of Chinese Academy of Sciences, Ningbo 315010, China; Ningbo Institute of Life and Health Industry, University of Chinese Academy of Science, Ningbo 315010, China; Key Laboratory of Diagnosis and Treatment of Digestive System Tumors of Zhejiang Province, Ningbo 315010, China; Department of Biochemistry and Molecular Biology, Zhejiang Key Laboratory of Pathophysiology, Medical School of Ningbo University, Ningbo 315211, China.

Life Sciences
|November 4, 2020
PubMed

Insights

Circular RNAs (circRNAs), stable molecules with unique loops, are linked to various liver diseases. Research highlights their role in disease progression and potential as diagnostic markers and therapeutic targets.

Area of Science:

  • Molecular Biology
  • Genetics
  • Hepatology

Background:

  • Circular RNAs (circRNAs) are covalently closed RNA molecules derived from precursor mRNA.
  • They exhibit high stability, abundance, and tissue-specific expression patterns.
  • Emerging evidence implicates circRNAs in the pathogenesis of diverse liver diseases.

Purpose of the Study:

  • To review the current research on the role of circRNAs in liver diseases.
  • To explore the diagnostic and prognostic potential of circRNAs.
  • To discuss the therapeutic implications of circRNAs in liver disease treatment.

Main Methods:

  • Literature review of studies investigating circRNAs in liver diseases.
  • Analysis of circRNA expression patterns and functional roles.
  • Evaluation of circRNAs as biomarkers and therapeutic targets.

Main Results:

  • CircRNAs are implicated in metabolic-associated fatty liver disease, hepatitis, liver cirrhosis, and hepatocellular carcinoma.
  • These molecules play significant roles in the progression of liver pathologies.
  • CircRNAs demonstrate potential as diagnostic and prognostic indicators.

Conclusions:

  • Circular RNAs are crucial players in liver disease development and progression.
  • CircRNAs hold promise as valuable biomarkers for liver disease diagnosis and prognosis.
  • Targeting circRNAs may offer novel therapeutic strategies for liver diseases.

Related Concept Videos

Types of RNA01:23

Types of RNA

Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
71.4K
Types of RNA01:20

Types of RNA

Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in regulating gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA Performs Diverse...
8.4K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
17.9K
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.4K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
118
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
4.0K